Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Kodiak Sciences Inc.KOD · Entity 4388 | See Remarks | June 24, 2023 | June 27, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Kodiak Sciences Inc.
Report date June 24, 2023 · Filed June 27, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.24 · Expires 2033-06-23 | Direct | 207,500 |
Reported balance
After 2023-06-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-06-24 · Grant · Acquired 207,500 · Balance 207,500 F1: One-forty-eighth (1/48th) of the shares vest one month after July 1, 2023 (the "Vesting Commencement Date"); the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments measured from the first month anniversary of the Vesting Commencement Date, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: One-forty-eighth (1/48th) of the shares vest one month after July 1, 2023 (the "Vesting Commencement Date"); the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments measured from the first month anniversary of the Vesting Commencement Date, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 22, 2021 Filed Feb 24, 2021 21:44 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 6,950 | $10.29 | $71,515.50 |
DisclosureSEC source: 0001209191-21-013834 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,293 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 22:22 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionStock Option (Right to Buy) · Derivative | 26,950 | $0.00 Strike: $10.29 | $0.00 |
DisclosureSEC source: 0001209191-21-004925 · doc4.xml · derivative · entry 10 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,275 Underlying: Common Stock · 26,950 shares Expires 2028-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019 and 1/48th of the shares subject to the option vest on the same day of each month thereafter. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 22:22 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,335 | $167.20 | $223,210.26 |
DisclosureSEC source: 0001209191-21-004925 · doc4.xml · nonDerivative · entry 9 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,343 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F9 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $167.14 to $167.68, inclusive. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 22:22 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 3,097 | $166.51 | $515,692.62 |
DisclosureSEC source: 0001209191-21-004925 · doc4.xml · nonDerivative · entry 8 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,678 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F8 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $166.12 to $167.00, inclusive. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 22:22 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 3,132 | $165.64 | $518,780.41 |
DisclosureSEC source: 0001209191-21-004925 · doc4.xml · nonDerivative · entry 7 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,775 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F7 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $165.11 to $166.04, inclusive. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 22:22 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,497 | $164.51 | $246,266.98 |
DisclosureSEC source: 0001209191-21-004925 · doc4.xml · nonDerivative · entry 6 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,907 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $164.03 to $164.91, inclusive. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 22:22 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 2,061 | $163.10 | $336,139.21 |
DisclosureSEC source: 0001209191-21-004925 · doc4.xml · nonDerivative · entry 5 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,404 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $162.75 to $163.68, inclusive. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 22:22 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 4,956 | $162.05 | $803,144.08 |
DisclosureSEC source: 0001209191-21-004925 · doc4.xml · nonDerivative · entry 4 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,465 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $161.70 to $162.65, inclusive. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 22:22 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 4,204 | $161.03 | $676,962.13 |
DisclosureSEC source: 0001209191-21-004925 · doc4.xml · nonDerivative · entry 3 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,421 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $160.56 to $161.51, inclusive. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 22:22 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 6,668 | $159.96 | $1,066,579.94 |
DisclosureSEC source: 0001209191-21-004925 · doc4.xml · nonDerivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,625 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $159.51 to $160.45, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 22:22 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 26,950 | $10.29 | $277,315.50 |
DisclosureSEC source: 0001209191-21-004925 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,293 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 23, 2020 Filed Dec 23, 2020 22:40 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $10.29 | $0.00 |
DisclosureSEC source: 0001209191-20-065054 · doc4.xml · derivative · entry 14 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 324,225 Underlying: Common Stock · 7,500 shares Expires 2028-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019 and 1/48th of the shares subject to the option vest on the same day of each month thereafter. Read SEC document |
| December 23, 2020 Filed Dec 23, 2020 22:40 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 7,500 | $10.29 | $77,175.00 |
DisclosureSEC source: 0001209191-20-065054 · doc4.xml · nonDerivative · entry 12 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 21, 2020 Filed Dec 23, 2020 22:40 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,950 | $0.00 Strike: $10.29 | $0.00 |
DisclosureSEC source: 0001209191-20-065054 · doc4.xml · derivative · entry 13 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 331,725 Underlying: Common Stock · 6,950 shares Expires 2028-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019 and 1/48th of the shares subject to the option vest on the same day of each month thereafter. Read SEC document |
| December 21, 2020 Filed Dec 23, 2020 22:40 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 82 | $148.78 | $12,199.96 |
DisclosureSEC source: 0001209191-20-065054 · doc4.xml · nonDerivative · entry 11 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,843 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. Read SEC document |
| December 21, 2020 Filed Dec 23, 2020 22:40 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 299 | $148.33 | $44,351.66 |
DisclosureSEC source: 0001209191-20-065054 · doc4.xml · nonDerivative · entry 10 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,925 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F10 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $148.17 to $148.39, inclusive. Read SEC document |
| December 21, 2020 Filed Dec 23, 2020 22:40 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,096 | $147.32 | $161,461.84 |
DisclosureSEC source: 0001209191-20-065054 · doc4.xml · nonDerivative · entry 9 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,224 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F9 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $147.02 to $147.68, inclusive. Read SEC document |
| December 21, 2020 Filed Dec 23, 2020 22:40 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,434 | $146.59 | $210,206.04 |
DisclosureSEC source: 0001209191-20-065054 · doc4.xml · nonDerivative · entry 8 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,320 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F8 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $146.13 to $146.95, inclusive. Read SEC document |
| December 21, 2020 Filed Dec 23, 2020 22:40 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 809 | $145.56 | $117,757.88 |
DisclosureSEC source: 0001209191-20-065054 · doc4.xml · nonDerivative · entry 7 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,754 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F7 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $145.25 to $146.00, inclusive. Read SEC document |
| December 21, 2020 Filed Dec 23, 2020 22:40 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 408 | $144.59 | $58,994.35 |
DisclosureSEC source: 0001209191-20-065054 · doc4.xml · nonDerivative · entry 6 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,563 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $144.00 to $145.00, inclusive. Read SEC document |
| December 21, 2020 Filed Dec 23, 2020 22:40 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 556 | $143.70 | $79,896.70 |
DisclosureSEC source: 0001209191-20-065054 · doc4.xml · nonDerivative · entry 5 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,971 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $142.96 to $143.92, inclusive. Read SEC document |
| December 21, 2020 Filed Dec 23, 2020 22:40 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 863 | $142.32 | $122,825.70 |
DisclosureSEC source: 0001209191-20-065054 · doc4.xml · nonDerivative · entry 4 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,527 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $141.73 to $142.58, inclusive. Read SEC document |
| December 21, 2020 Filed Dec 23, 2020 22:40 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,016 | $140.76 | $143,012.97 |
DisclosureSEC source: 0001209191-20-065054 · doc4.xml · nonDerivative · entry 3 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,390 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $140.41 to $141.14, inclusive. Read SEC document |
| December 21, 2020 Filed Dec 23, 2020 22:40 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 387 | $139.29 | $53,903.33 |
DisclosureSEC source: 0001209191-20-065054 · doc4.xml · nonDerivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,406 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $139.26 to $139.73, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. Read SEC document |
| December 21, 2020 Filed Dec 23, 2020 22:40 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 6,950 | $10.29 | $71,515.50 |
DisclosureSEC source: 0001209191-20-065054 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,793 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 23:04 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,950 | $0.00 Strike: $10.29 | $0.00 |
DisclosureSEC source: 0001209191-20-060307 · doc4.xml · derivative · entry 9 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,675 Underlying: Common Stock · 6,950 shares Expires 2028-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019 and 1/48th of the shares subject to the option vest on the same day of each month thereafter. Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 23:04 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 57 | $140.88 | $8,029.88 |
DisclosureSEC source: 0001209191-20-060307 · doc4.xml · nonDerivative · entry 8 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,843 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 23:04 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 2,614 | $139.96 | $365,865.90 |
DisclosureSEC source: 0001209191-20-060307 · doc4.xml · nonDerivative · entry 7 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,900 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F7 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $139.795 to $140.415, inclusive. Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 23:04 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 2,134 | $139.39 | $297,453.99 |
DisclosureSEC source: 0001209191-20-060307 · doc4.xml · nonDerivative · entry 6 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,514 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $138.90 to $139.755, inclusive. Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 23:04 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 981 | $138.56 | $135,927.36 |
DisclosureSEC source: 0001209191-20-060307 · doc4.xml · nonDerivative · entry 5 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,648 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $137.91 to $138.79, inclusive. Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 23:04 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 400 | $137.27 | $54,906.80 |
DisclosureSEC source: 0001209191-20-060307 · doc4.xml · nonDerivative · entry 4 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,629 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $136.87 to $137.81, inclusive. Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 23:04 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 259 | $134.72 | $34,892.22 |
DisclosureSEC source: 0001209191-20-060307 · doc4.xml · nonDerivative · entry 3 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,029 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $134.46 to $134.93, inclusive. Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 23:04 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 505 | $133.71 | $67,525.07 |
DisclosureSEC source: 0001209191-20-060307 · doc4.xml · nonDerivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,288 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $133.315 to $133.93, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 23:04 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 6,950 | $10.29 | $71,515.50 |
DisclosureSEC source: 0001209191-20-060307 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,793 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 27, 2020 Filed Oct 29, 2020 20:49 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $10.29 | $0.00 |
DisclosureSEC source: 0001209191-20-056242 · doc4.xml · derivative · entry 3 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345,625 Underlying: Common Stock · 7,500 shares Expires 2028-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019 and 1/48th of the shares subject to the option vest on the same day of each month thereafter. Read SEC document |
| October 27, 2020 Filed Oct 29, 2020 20:49 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 7,500 | $100.00 | $750,000.00 |
DisclosureSEC source: 0001209191-20-056242 · doc4.xml · nonDerivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,843 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. Read SEC document |
| October 27, 2020 Filed Oct 29, 2020 20:49 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 7,500 | $10.29 | $77,175.00 |
DisclosureSEC source: 0001209191-20-056242 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 23, 2020 Filed Oct 27, 2020 20:57 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $10.29 | $0.00 |
DisclosureSEC source: 0001209191-20-055929 · doc4.xml · derivative · entry 3 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 353,125 Underlying: Common Stock · 7,500 shares Expires 2028-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019 and 1/48th of the shares subject to the option vest on the same day of each month thereafter. Read SEC document |
| October 23, 2020 Filed Oct 27, 2020 20:57 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 7,500 | $86.25 | $646,875.00 |
DisclosureSEC source: 0001209191-20-055929 · doc4.xml · nonDerivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,843 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. Read SEC document |
| October 23, 2020 Filed Oct 27, 2020 20:57 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 7,500 | $10.29 | $77,175.00 |
DisclosureSEC source: 0001209191-20-055929 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 20, 2020 Filed Oct 22, 2020 20:56 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,950 | $0.00 Strike: $10.29 | $0.00 |
DisclosureSEC source: 0001209191-20-055577 · doc4.xml · derivative · entry 5 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,625 Underlying: Common Stock · 6,950 shares Expires 2028-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019 and 1/48th of the shares subject to the option vest on the same day of each month thereafter. Read SEC document |
| October 20, 2020 Filed Oct 22, 2020 20:56 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 3,214 | $79.13 | $254,322.21 |
DisclosureSEC source: 0001209191-20-055577 · doc4.xml · nonDerivative · entry 4 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,843 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $78.74 to $79.40, inclusive. Read SEC document |
| October 20, 2020 Filed Oct 22, 2020 20:56 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 3,397 | $77.88 | $264,552.59 |
DisclosureSEC source: 0001209191-20-055577 · doc4.xml · nonDerivative · entry 3 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,057 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $77.49 to $78.44, inclusive. Read SEC document |
| October 20, 2020 Filed Oct 22, 2020 20:56 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 339 | $76.53 | $25,942.69 |
DisclosureSEC source: 0001209191-20-055577 · doc4.xml · nonDerivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,454 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $76.07 to $76.85, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. Read SEC document |
| October 20, 2020 Filed Oct 22, 2020 20:56 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 6,950 | $10.29 | $71,515.50 |
DisclosureSEC source: 0001209191-20-055577 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,793 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 13, 2020 Filed Oct 15, 2020 21:44 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $10.29 | $0.00 |
DisclosureSEC source: 0001209191-20-054929 · doc4.xml · derivative · entry 3 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 367,575 Underlying: Common Stock · 5,000 shares Expires 2028-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019 and 1/48th of the shares subject to the option vest on the same day of each month thereafter. Read SEC document |
| October 13, 2020 Filed Oct 15, 2020 21:44 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 5,000 | $75.00 | $375,000.00 |
DisclosureSEC source: 0001209191-20-054929 · doc4.xml · nonDerivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,843 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. Read SEC document |
| October 13, 2020 Filed Oct 15, 2020 21:44 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 5,000 | $10.29 | $51,450.00 |
DisclosureSEC source: 0001209191-20-054929 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,843 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 23:04 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionRestricted Stock Units · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-054733 · doc4.xml · derivative · entry 6 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. F7 · derivative.exercise_date: 50% of the RSU vested 12 months after October 9, 2018 (the "Grant Date"), 25% of the RSU vested 18 months after the Grant Date and 25% of the RSU vest 24 months after the Grant Date. F7 · derivative.expiration_date: 50% of the RSU vested 12 months after October 9, 2018 (the "Grant Date"), 25% of the RSU vested 18 months after the Grant Date and 25% of the RSU vest 24 months after the Grant Date. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 23:04 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 896 | $72.14 | $64,633.05 |
DisclosureSEC source: 0001209191-20-054733 · doc4.xml · nonDerivative · entry 5 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,843 F3 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. These sales were made to cover tax withholding obligations in connection with vesting and settlement of 25% of the Reporting Person's RSU granted on October 9, 2018. F6 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $71.91 to $72.57, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.